We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+2.37%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$10.8B
AUM Growth
+$988M
Cap. Flow
+$812M
Cap. Flow %
7.54%
Top 10 Hldgs %
14.36%
Holding
2,596
New
200
Increased
685
Reduced
635
Closed
273

Top Buys

Rank Stock Value
1
VEU icon
Vanguard FTSE All-World ex-US ETF
VEU
+$32.7M
2
LLY icon
Eli Lilly
LLY
+$31M
3
LZB icon
La-Z-Boy
LZB
+$17.4M
4
UI icon
Ubiquiti
UI
+$17.1M
5
TRS icon
TriMas Corp
TRS
+$16.1M

Top Sells

Rank Stock Value
1
LXU icon
LSB Industries
LXU
+$14M
2
K
Kellanova
K
+$13.7M
3
AAPL icon
Apple
AAPL
+$13.1M
4
PB icon
Prosperity Bancshares
PB
+$11.7M
5
FLR icon
Fluor
FLR
+$11.7M

Sector Composition

Rank Sector Weight
1 Technology 13.72%
2 Industrials 12.7%
3 Healthcare 12.22%
4 Financials 10.93%
5 Energy 9.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EPAC icon
1301
Enerpac Tool Group
EPAC
$1.78B
$101K ﹤0.01%
2,958
-9
-0.3% -$311
PENN icon
1302
PENN Entertainment
PENN
$2.83B
$101K ﹤0.01%
8,200
-1,000
-11% -$12.3K
VHT icon
1303
Vanguard Health Care ETF
VHT
$18.3B
$101K ﹤0.01%
960
KYN.PRG
1304
DELISTED
KAYNE ANDERSON MLP INVESTMENT CO PFD SHS SER G
KYN.PRG
$101K ﹤0.01%
+4,000
New +$101K
MSI icon
1305
Motorola Solutions
MSI
$70.3B
$100K ﹤0.01%
1,585
-5,357
-77% -$350K
SPLS
1306
DELISTED
Staples Inc
SPLS
$99K ﹤0.01%
8,821
-5,188
-37% -$67.8K
DNY
1307
DELISTED
DONNELLEY R R & SONS CO
DNY
$99K ﹤0.01%
5,600
-3,400
-38% -$60.1K
AB icon
1308
AllianceBernstein
AB
$3.54B
$98K ﹤0.01%
4,000
+1,000
+33% +$23.4K
GDXJ icon
1309
VanEck Junior Gold Miners ETF
GDXJ
$7.15B
$98K ﹤0.01%
2,725
-900
-25% -$34.7K
RALY
1310
DELISTED
RALLY SOFTWARE DEV CORP
RALY
$98K ﹤0.01%
7,334
-102
-1% -$2.03K
CP icon
1311
Canadian Pacific Kansas City
CP
$81.1B
$97K ﹤0.01%
3,240
PVG
1312
DELISTED
PRETIUM RESOURCES INC.
PVG
$97K ﹤0.01%
17,000
ICON
1313
DELISTED
Iconix Brand Group, Inc.
ICON
$97K ﹤0.01%
250
-108
-30% -$42K
CNA icon
1314
CNA Financial
CNA
$14.7B
$96K ﹤0.01%
2,250
-652
-22% -$27.1K
CVE icon
1315
Cenovus Energy
CVE
$52.3B
$96K ﹤0.01%
3,320
GAU
1316
Galiano Gold
GAU
$478M
$96K ﹤0.01%
+46,800
New +$93.1K
HLIO icon
1317
Helios Technologies
HLIO
$2.59B
$96K ﹤0.01%
2,225
IMAX icon
1318
IMAX
IMAX
$2.47B
$96K ﹤0.01%
3,513
+2,957
+532% +$80.8K
SHEN icon
1319
Shenandoah Telecom
SHEN
$637M
$96K ﹤0.01%
6,000
CCMP
1320
DELISTED
CMC Materials, Inc. Common Stock
CCMP
$96K ﹤0.01%
2,191
MWIV
1321
DELISTED
MWI VETERINARY SUPPLY, INC.
MWIV
$96K ﹤0.01%
621
XLY icon
1322
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$21.6B
$95K ﹤0.01%
2,950
OB
1323
DELISTED
Onebeacon Insurance Group Ltd
OB
$95K ﹤0.01%
6,200
EGP icon
1324
EastGroup Properties
EGP
$11.3B
$94K ﹤0.01%
1,500
IYF icon
1325
iShares US Financials ETF
IYF
$4.68B
$94K ﹤0.01%
2,300

Similar funds

Glenmede Trust's Q1 2014 Portfolio in Review

As of Q1 2014, Glenmede Trust held 2,596 positions worth $10.8B, up 10% from $9.79B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Glenmede Trust deployed $812M of net new capital in Q1 2014, opening 200 new positions and adding to 685 existing holdings. Its largest new stake was Vanguard FTSE All-World ex-US ETF: 661,076 shares worth $33.3M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Kellanova, an estimated $13.7M trimmed.

  • Glenmede Trust's largest Q1 2014 buy was Vanguard FTSE All-World ex-US ETF: 661,076 shares worth $33.3M.
  • Glenmede Trust added most to Eli Lilly in Q1 2014, an estimated $31M increase.
  • Glenmede Trust's biggest Q1 2014 reduction was Kellanova, cutting an estimated $13.7M.
  • Glenmede Trust fully exited LSB Industries in Q1 2014, selling an estimated $14M.
  • Glenmede Trust's ten largest holdings make up 14% of its $10.8B portfolio in Q1 2014.
  • Glenmede Trust opened 200 new positions and closed 273 in Q1 2014.
  • Glenmede Trust's portfolio value rose 10% quarter-over-quarter to $10.8B.

Based on Glenmede Trust's 13F filing for Q1 2014, filed 7 May 2014.